Santa Cruz Biotechnology offers a broad range of Salmonella core antigen monoclonal antibodies for research focused on understanding Salmonella infections and their impact on human health. Salmonella core antigen Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Salmonella core antigens play a crucial role in the immune response to Salmonella infections, serving as key targets for diagnostic and therapeutic applications. Understanding Salmonella core antigens is essential for developing effective vaccines and treatments, as they are involved in the pathogenesis of Salmonella and contribute to its virulence. The study of Salmonella core antigens can provide insights into bacterial behavior and host interactions, which are vital for advancing public health measures. Researchers worldwide rely on Salmonella core antigen monoclonal antibodies to advance their understanding of bacterial pathogenesis and host-pathogen interactions. Current investigations utilizing Salmonella core antigen monoclonal antibodies focus on developing novel therapeutic strategies and improving diagnostic methods. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to the scientific community's understanding of Salmonella-related diseases and potential treatments.